Progressive Supranuclear Palsy

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects movement, gait, balance, and speech. Discover the latest research on PSP here.

May 13, 2020

Magnetic Resonance Imaging Biomarkers Distinguish Normal Pressure Hydrocephalus From Progressive Supranuclear Palsy

Movement Disorders : Official Journal of the Movement Disorder Society
Andrea QuattroneAldo Quattrone
June 17, 2020
Open Access

Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study

Parkinsonism & Related Disorders
Cèlia PainousYaroslau Compta
May 27, 2020

Spectrum of Frontotemporal Lobar Degeneration on 18F-FDG PET/CT Scan

Clinical Nuclear Medicine
Nikhil SeniarayHarsh Mahajan
May 12, 2020

Is brain perfusion a differentiating feature in the comparison of Progressive Supranuclear Palsy Syndrome (PSPS) and Corticobasal Syndrome (CBS)?

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Piotr AlsterAndrzej Friedman
May 23, 2020
Review
Open Access

Frontotemporal Dementia: Neuropathology, Genetics, Neuroimaging, and Treatments

The Psychiatric Clinics of North America
Kyan Younes, Bruce L Miller
June 25, 2020

Identification of Conserved Proteomic Networks in Neurodegenerative Dementia

Cell Reports
Vivek SwarupDaniel H Geschwind
May 28, 2020
Review
Open Access

Clinical and Imaging Markers of Prodromal Parkinson's Disease

Frontiers in Neurology
Eldbjørg Hustad, Jan O Aasly
May 2, 2020

Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism

Movement Disorders : Official Journal of the Movement Disorder Society
Derek B ArcherDavid E Vaillancourt
May 14, 2020

DCTN1 mutation analysis in Italian patients with PSP, MSA, and DLB

Neurobiology of Aging
Radha ProcopioGrazia Annesi
July 3, 2020
Open Access

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism

Frontiers in Aging Neuroscience
Rocco CerroniRenato Massoud
June 13, 2020

LRP10 variants in progressive supranuclear palsy

Neurobiology of Aging
Leonie J M VergouwFrank Jan de Jong
July 6, 2020

Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers

Parkinsonism & Related Disorders
Stephanie MangesiusWerner Poewe
April 23, 2020
Open Access

Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy

Journal of Clinical Neurology
Young Eun KimYun Joong Kim
May 26, 2020
Preprint
Open Access

Neuroinflammation predicts disease progression in progressive supranuclear palsy

MedRxiv : the Preprint Server for Health Sciences
M. MalpettiJames B Rowe
June 18, 2020
Open Access

Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages

Frontiers in Neurology
Suzanne M ShdoKatherine P Rankin
May 9, 2020
Open Access

Distribution patterns of tau pathology in progressive supranuclear palsy

Acta Neuropathologica
Gabor G KovacsGünter U Höglinger

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/progressive-supranuclear-palsy/74d585e5-85bd-4f41-b8b5-ad129100b4a1